Study of Decitabine Induction Prior to Allogeneic Hematopoietic Cell Transplant in Newly Diagnosed MDS Patients

NCT01333449 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Poor subject accrual

Conditions

Myelodysplastic Syndrome

Interventions

DRUG: Decitabine

Sponsor

Singapore General Hospital

Collaborators

[object Object]